title: Predictive value of remission status after 6 months induction therapy in patients with proliferative lupus nephritis: a retrospective analysis.
abstract: The objective of this study was to evaluate whether remission status after completion of induction therapy can be used to predict long-term renal outcomes, including renal relapse and chronic renal failure (CRF) in patients with proliferative lupus nephritis (LN). Of 201 patients with biopsy proven LN between 1998 and 2008, 117 were reviewed. Fifty nine (50.4%), 33 (28.2%), and 25 (21.4%) were assigned to the complete remission (CR), partial remission (PR), and non-remission (NR) groups, respectively. The 24-h urinary protein level was significantly lower in the CR than in the PR and NR groups. Induction therapy after the first detection of nephritis signs was initiated earlier in the CR than in the PR and NR groups. During follow-up, 36 (39.1%) patients suffered relapse. Multivariate analysis showed that longer latency period and a lack of CR were independent predictors of renal relapse. Seventeen (14.5%) patients experienced CRF. Multivariate analysis showed that higher baseline creatinine concentration and a lack of CR after induction therapy were independent predictors of CRF. We found that renal outcomes were related to remission status after 6 months induction therapy in patients with proliferative LN. Further, poor outcomes were associated with delayed intervention and higher creatinine concentration.
authors: Division of Rheumatology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Pungnap-dong, Songpa-gu, Seoul, South Korea.
authors: Min Wook
authors: MW
authors: So
authors: Bon San
authors: BS
authors: Koo
authors: Yong-Gil
authors: YG
authors: Kim
authors: Chang-Keun
authors: CK
authors: Lee
authors: Bin
authors: B
authors: Yoo
references: Am J Med. 1987 Nov;83(5):877-85
references: 3674094
references: Kidney Int. 1994 Feb;45(2):544-50
references: 8164443
references: Lupus. 1995 Jun;4(3):197-203
references: 7655489
references: Lupus. 2002;11(2):82-7
references: 11958582
references: Rheumatology (Oxford). 2008 Mar;47(3):311-4
references: 18204087
references: Clin Nephrol. 2002 Feb;57(2):114-9
references: 11863120
references: Lupus. 1992 Feb;1(2):97-103
references: 1301970
references: Q J Med. 1989 Sep;72(269):779-833
references: 2694209
references: Arthritis Rheum. 2002 Apr;46(4):1003-13
references: 11953978
references: Am J Med. 1983 Sep;75(3):382-91
references: 6351607
references: Rheum Dis Clin North Am. 1994 Feb;20(1):213-42
references: 8153400
references: Arthritis Rheum. 2004 Dec;50(12):3934-40
references: 15593207
references: Ann Rheum Dis. 2003 May;62(5):435-9
references: 12695156
references: N Engl J Med. 2004 Mar 4;350(10):971-80
references: 14999109
references: J Rheumatol. 2006 Aug;33(8):1563-9
references: 16881113
references: Lupus. 2005;14(4):265-72
references: 15864912
references: Lancet. 1992 Sep 26;340(8822):741-5
references: 1356175
references: Am J Kidney Dis. 2000 May;35(5):904-14
references: 10793026
references: Kidney Int. 1992 Sep;42(3):743-8
references: 1405352
references: Ann Intern Med. 1996 Oct 1;125(7):549-57
references: 8815753
references: Am J Kidney Dis. 1999 Aug;34(2):315-23
references: 10430980
references: Am J Med. 2006 Apr;119(4):355.e25-33
references: 16564783
references: Arthritis Rheum. 1990 Jul;33(7):970-7
references: 2369432
references: Lupus. 2005;14(11):890-5
references: 16335581
references: J Am Soc Nephrol. 1999 Feb;10(2):413-24
references: 10215343
references: Kidney Int. 2000 Jan;57(1):258-64
references: 10620207
references: Clin J Am Soc Nephrol. 2008 Jan;3(1):46-53
references: 18003764
references: Rheumatology (Oxford). 2002 Sep;41(9):981-7
references: 12209030
references: N Engl J Med. 1986 Mar 6;314(10):614-9
references: 3511372